Method of treating an epstein-barr viral infection

Details Method of treating an epstein-barr viral infection Method of treating an epstein-barr viral infection

1992-08-24

1994-08-02

Robinson, Douglas W.

Drug, bio-affecting and body treating compositions

Extract, body fluid, or cellular material of undetermined...

Digestive system

514 21, 514885, 530846, A61K 35407

Patent

active

053343956

ABSTRACT:
A therapeutic method for treating Epstein-Barr virus infection. The method comprises administering a therapeutically-effective amount of a mammalian liver extract, the extract being characterized by being heat stable, insoluble in acetone and soluble in water, peptide or peptide fragment selected from the groups consisting of Sequence Identification Numbers 1-9.

REFERENCES:
patent: 3778510 (1973-12-01), Blonde
patent: 4148788 (1979-04-01), Wang
patent: 4420398 (1983-12-01), Castino
patent: 4426324 (1984-01-01), Meienhofer
patent: 4428938 (1984-01-01), Kisfaludy
patent: 4464355 (1984-08-01), Fabricius
patent: 4468379 (1984-08-01), Gottlieb
patent: 4537878 (1985-08-01), Plotnikoff
patent: 4595588 (1986-06-01), Baron
patent: 4595780 (1986-06-01), Ogata
patent: 4596798 (1986-06-01), Shipman, Jr.
patent: 4598095 (1986-07-01), Nishimura
patent: 4602037 (1986-07-01), Seborm
patent: 4603122 (1986-07-01), Blough
patent: 4603219 (1986-07-01), Verheyden
patent: 4604404 (1986-08-01), Munson, Jr.
patent: 4605658 (1986-08-01), Holy
patent: 4605659 (1986-08-01), Verheyden
patent: 4606917 (1986-08-01), Eppstein
patent: 4609661 (1986-09-01), Verheyden
patent: 4609662 (1986-09-01), Krenitsky
patent: 4612314 (1986-09-01), Verheyden
patent: 4614651 (1986-09-01), Jarvis, Jr.
patent: 4614731 (1986-09-01), Horecker
patent: 4617304 (1986-10-01), Ashton
patent: 4621140 (1986-11-01), Verheyden
patent: 4622430 (1986-11-01), Dekker
patent: 4625026 (1986-11-01), Kim
patent: 4626524 (1986-12-01), Server
patent: 4628063 (1986-12-01), Haines
patent: 4629811 (1986-12-01), Dominianni
patent: 4631149 (1986-12-01), Rinehart, Jr.
patent: 4644055 (1987-02-01), Kettner
patent: 4668660 (1987-05-01), Paessens
patent: 4670437 (1987-06-01), Abdulla
patent: 4699898 (1987-10-01), Gottlieb
patent: 4708818 (1987-11-01), Montagnier
patent: 4710380 (1987-12-01), Gottlieb
Andrews et al., JAMA, 146, 1107 (1951).
Barksdale, South. Med. Jour., 50, 1524 (1957).
Barksdale, et al., Virginia Medical Monthly, 81, 321 (1954).
Barrock, Medical Times, 1, (Aug. 1958).
Boreen, Minnesota Medicine, 25, 276 (1942).
Burks, Jr. Journal of the Louisiana Medical Society, 106, 92 (1954).
Burks, Jr. and Knox Archives of Dermatology and Syphilology, 70 508 (1954).
Center for Disease Control, Dept. Health and Human Services, Chronic Fatigue Syndrome, Mar. 22, 1988.
Chase, Wall Street Journal, Apr. 28, 1988, at 14, at col. 1.
Gaskell, Brit. Med. J., 1037 (Jun. 11, 1949).
Gathings, Am. J. Surgery, 88, 429 (1954).
Gladner, Ann. N.Y. Aca. Sci 47.
Harris, et al., Oral Surgery, 7, 239 (1954).
Hellinger, et al., JAMA, 260, 971 (Aug. 19, 1988).
Heywood, Clinical Medicine, 3, 425 (1956).
Hjerten, Archives of Biochemistry and Biophysics, Suppl. 1, 147 (1962).
Hjertsen and Mosbach, Analytical Biochemistry, 3, 109 (1962).
Holtman, Oral Surgery, 7, 12 (1954).
Judge, Proc. Soc. Exptl. Biol. Med., 123, 199 (1966).
Kozelka and Marshall, Clinical Medicine, 3, 245 (1956).
Kutapressin-Drug Package Insert, Kremers-Urban.
Li, et al., Nature, 219, 1163 (Sep. 14, 1968).
Li, et al., Proc Soc. Exptl. Biol. Med., 114, 504 (1963).
Li, et al., Proc. Soc. Exptl. Biol. Med., 109, 534 (1962).
Li, et al., J. Nat'l Cancer Inst., 41, 1249 (Nov. 1968).
Li, et al., Ann. N.Y. Acad. Sci., 130, 374 (1965).
Lichtenstein and Stillians, Arch. Dermatology and Syphilology, 45, 595 (1942).
Lubowe, Clinical Medicine, 59, 8 (1952).
Marshall, et al., Am. J. Surgery, 90, 47 (1955).
Marshall, Maryland State Med. J., (Jun. 1960).
Marshall, Am. J. Surgery, 84(6), 675 (1952).
Marshall, and Schadeberg, Wisconsin Medical Journal, 49, 369 (1950).
Marshall and Schadeberg, Indian J. Veneral Diseases, 16, 89 (1950).
Marshall, J.M.A. Alabama, 13, 255 (1944).
Marshall, Mississippi Valley Med. J., 61, 172 (1939).
Marshall, Med. World, 57, 101 (1939).
Marshall, Northwest Medicine, 38, 467 (1939).
Marshall, J. Invest. Derm., 2, 105 (1939).
Marshall, A. J. Surgery, 448 (Oct. 1951).
Marshall, Medical Times, 70, 222 (1951).
Marshall, Indian J. Veneral Diseases and Dermatology, 20, 99 (1954).
Marshall, The Journal-Lancet, 60, 117 (1940).
Marshall, Minnesota Medicien, 25, 796 (1942).
Marshall, Arizona Medicine, 14(1), 11 (1957).
Marshall, Mississippi Valley Med. J., 76, 199 (1954).
Mitchell-Heggs, Brit. Med. J., 2, 1079 (1951).
Montefiori, et al., J. Clin. Micro., 26, 231 (Feb. 1988).
Montefiori and Mitchell, Proc. Nat'l Acad. Sci. U.S.A., 84(9), 2985 (May 1987).
Nierman, Journal of the Indiana State Medical Association, 45, 497 (1952).
Osbahr, et al., Biochim. Biophys. Acta. 86, 535 (1964).
Pensky and Goldberg, The Journal-Lancet, 75(11), 490 (Nov. 1955).
Pensky and Goldberg, New York State Journal of Medicine, 53, 2238 (1953).
Pharmacopeia of the United States, 15, 379.
Pollner, Medical World News, 35 (Jun. 13, 1988).
Poole, South Med. J., 50, 207 (1957).
Ruggieri, Science, 194, 491 (1976)
Schmeer and Huala, Ann. N.Y. Acad. Sci., 118, 605 (1965).
Schmeer, Science, 144, 413 (1964).
Smith, HIV and Other Highly Pathogenic Viruses, Academic Press, Inc. (1988)
Stillians, Mississippi Valley Medical Journal, 64, 135 (1942).
Stokes and Sternberg, Archives of Dermatology and Syphilology, 40, 345 (1939).
Sutton, Archives of Dermatology and Syphilology, 18, 887 (1928).
Tewksbury and Stahmann, Arch. Biochem. Biophys. (U.S.), 112, 453 (1965).
Tewksbury, Archives Int'l de Pharmacodynamic et de Therapie, 173, 426 (1968).
Tewksbury, Dissertation Absttracts International-Part II, 25-04, 2214 (1964).
Walters, Ohio State Medical Journal, 44, 697 (1948).
van der Horst, et al., "Lack of Effect of Peroral Acyclovir for the Treatment of Acute Infectious Mononucleosis", The Journal of Infectious Diseases, 1991; 164:788-92.

Affiliated with

Also associated with

Rating

Method of treating an epstein-barr viral infection does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Method of treating an epstein-barr viral infection, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of treating an epstein-barr viral infection will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-63894